SCHEMBL7498083

SCHEMBL7498083

CCC(C)c1nc(CO)c(SCc2ccc(OC)cc2)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
KMT2A Q03164 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.41
MMP13 P45452 1/20 0.41
CYP1A2 P05177 6/20 0.40
CYP2E1 P05181 6/20 0.40
CYP3A4 P08684 6/20 0.40
CYP2C8 P10632 6/20 0.40
CYP2D6 P10635 6/20 0.40
CYP2C9 P11712 6/20 0.40
CYP2B6 P20813 6/20 0.40
CYP2C19 P33261 6/20 0.40
TP53 P04637 1/20 0.40
CTSB P07858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7498585 0.81 LMNA (0.42) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL7491479 0.80 NPC1 (0.38) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL7498087 0.77 NPC1 (0.46) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL7489820 0.73 LMNA (0.39) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL3841049 0.69 FFAR1 (0.49) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL8043911 0.68 TARBP2 (0.46) NPC1RAB9AMEN1NFKB1NFKB2
Methane SCHEMBL7498094 0.65 NPC1 (0.46) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL4286908 0.62 LMNA (0.63) NPC1RAB9AMEN1NFKB1NFKB2
SCHEMBL10064850 0.62 IDO1 (0.55) SMN1; SMN2CYP3A4TP53DAOAPP
SCHEMBL1253525 0.61 LMNA (0.46) SMN1; SMN2LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0638572-B1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them AVENTIS PHARMA SA (FR) 2002-12-04 EP disclosed